Allergy

Blepharitis

COVID-19

Cataract

Comanagement

Comprehensive Eye Exams

Conjunctivitis

Contact Lenses

Cornea

Diabetic Eye Disease

Dry Eye

Geographic Atrophy

Glasses

Glaucoma

LASIK

Lens Technology

Lid and Lash

Myopia

Nutrition

Ocular Surface Disease

Optic Relief

Patient Care

Pediatrics

Presbyopia

Ptosis

Refractive Surgery

Retina

Technology

Therapeutic Cataract & Refractive

News

All News

Practice Management

Media

All Videos

Expert Interviews

Podcasts

Medical World News

Viewpoints

Insights

Case Based Roundtable Series

Case Studies

Case of the Quarter

Practice Ownership

Rapid Readout

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Conference Recaps

Blog

Publications

Digital Edition

Supplements And Featured Publications

iTech

Partners

Resources

Job Board

Subscribe

Slideshows

Catch up on the top stories in optometry during the week of September 8-September 12.

Takeaways from this week in optometry: September 8- September 12

Articles

Long-term atropine use to treat myopia associated with increased risk of ocular complication in schoolchildren in Taiwan

A total of 293 optometrists, practice owners, and managers were involved in the survey.

Myopia treatment trends outlined in The Vision Council's recent report

Researchers conducted this study to determine how often and why spontaneous soft drusen regresses without atrophy in patients who had intermediate or atrophic age-related macular degeneration.

New study examines soft drusen regression without atrophy and drusen ooze

Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.

Advertise

About Us

Editorial

Contact Us

Terms & Conditions

Privacy

Do not sell my Information

Optometry Times – Clinical News & Expert Optometrist Insights

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Myopia- Management

1rem

Clinical Focus

Exploring strategies for effective management of a multifaceted condition.

Utilizing the immune system to combat dry eye disease

The silicone hydrogel daily disposable lenses contain a blend of osmoprotectants, electrolytes, and moisturizers to provide stable vision and keep eyes comfortable for 16 hours.

Bausch + Lomb launches new INFUSE for Astigmatism contact lenses in the US

The agreement redefines participant requirements and a slightly increased daily release of the drug, which is currently in a Phase 3 clinical trial.

FDA approves agreement modification for Ocular Therapeutix to amend Special Protocol Assessment for AXPAXLI

Allergy testing and immunotherapy are the recommended steps to improve symptoms.

Looking forward to improving and lessening the allergic response 

Optic relief: Losing steps

Jade Coats, OD, gives an overview on a talk on ocular pain and patient care

AOA 2024: Managing ocular pain and what it means for patient care

Ocular pain and its treatment and referral can vary greatly from one patient to another. Jade Coats, OD, alongside Jacqueline Theis, OD, FAAO, and Cory Lappin, OD, MS, FAAO, differentiated some of the factors of pain and what the best plan of action may be for these patients in a talk given at AOA's Optometry's Meeting in Nashville, Tennessee, running from June 19-22.

This transcript has been lightly edited for clarity.

Hi my name is Jade Coats and I practice at McDonald Eye Associates in northwest Arkansas. Today I'm really excited to lecture at AOA with Dr. Cory Lappin and Dr. Jacqueline Theis as we review managing ocular pain in our patients, patients acutely in need. And for us what this means is we really need to dive to the root of the issue, addressing dry eye as soon and as quickly as possible to prevent neurotrophic pain, which may lead to other neuropathic pain. And so for us, what we're going to provide is maybe different perspectives. From an OD/MD perspective, a dry eye center perspective, and a neuro perspective. And all of these perspectives are going to help us maybe clue you into the different correct options to treat pain across the board.

So in my clinic, I typically see more pain that might result from an acute trauma. And so my pain is very, very differently treated, then maybe something a type of pain seen in Dr. Theis's clinic, or Dr. Lappin's clinic. Their version of pain may be something that could be more associated with the ocular surface. And so that's what we're here trying to highlight is that although we're seeing patients who are complaining of "pain," they may be very, very different, how they're referred, how they're interpreted by the brain, and how we treat them.

Videos

Jade Coats, OD, alongside Jacqueline Theis, OD, FAAO, and Cory Lappin, OD, MS, FAAO, gave a talk on ocular pain and patient care at AOA's 2024 Optometry's Meeting.

Conference

Optic Relief

Latest News